Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice

MLA

Robert Geffers, et al. Targeting a Host-Cell Entry Factor Barricades Antiviral-Resistant HCV Variants from on-Therapy Breakthrough in Human-Liver Mice. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6a09e6abe863a0979c6447571a135df5&authtype=sso&custid=ns315887.

APA

Robert Geffers, Alfredo Nicosia, Thomas F. Baumert, Lieven Verhoye, Fulvia Troise, Jonathan K. Ball, Sabin Bhuju, Riccardo Cortese, Ali Farhoudi, Philip Meuleman, Ahmed Atef Ahmed Abouzeid Mesalam, Koen Vercauteren, Juliane Doerrbecker, Naomi Van den Eede, Richard J. C. Brown, Geert Leroux-Roels, Thomas Pietschmann, & C. Patrick McClure. (2016). Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice.

Chicago

Robert Geffers, Alfredo Nicosia, Thomas F. Baumert, Lieven Verhoye, Fulvia Troise, Jonathan K. Ball, Sabin Bhuju, et al. 2016. “Targeting a Host-Cell Entry Factor Barricades Antiviral-Resistant HCV Variants from on-Therapy Breakthrough in Human-Liver Mice,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6a09e6abe863a0979c6447571a135df5&authtype=sso&custid=ns315887.